Latest on Pharmaceutical Industry


Moleculin Enters Agreement with BSP Pharmaceuticals for its Leukemia Drug Candidate

Moleculin Biotech, Inc., a clinical stage pharmaceutical company focused on the development of oncology drug candidates, all of which are based on license agreements with The University of Texas System on behalf of the M..Read More...

AstraZeneca flop a fresh blow to cancer immunotherapy combination

The concept of combining two immunotherapy drugs to fight lung cancer - not so long ago one of the hottest ideas in cancer research - has suffered a fresh blow from the failure of an AstraZeneca (AZN.L) clinical study. ..Read More...



World Orphan Drug Congress USA 2018

Gaylord National Harbor Hotel,
Terrapinn Holdings Ltd.


11th European Biosimilars Congress

Conference Series

Press Releases

Lin BioScience Announces FDA Orphan Drug Designation for LBS-007 for the Treatment of Acute Lymphoblastic Leukemia

Lin BioScience a drug development company targeting unmet clinical needs in oncology ophthalmology and metabolic diseases announced today that the US Food and Drug Administration FDA has granted Orphan Drug Designation O.. Read More...

Tarveda Therapeutics Announces Dosing of First Patient in Phase 1/2a Study of PEN-866 for Patients with Solid Malignancies

Tarveda Therapeutics Inc a clinical stage biopharmaceutical company discovering and developing Pentarins as a new class of potent and selective cancer medicines today announced that it has dosed the first patient in a Ph.. Read More...

Suppliers of the Month

Product Launch



Latest Reports


Latest Projects


Expert Talk

Aurena Laboratories AB

Aurena Laboratories AB Aurena business model is to offer support brand owners to launch innovative and competitive products with shortest possible time to market We produce the product to companies around the world. Read More...
Magnus Hedman
Director Business Development Marketing